Consequences of a high phosphorus intake on mineral metabolism and bone remodeling in dependence of calcium intake in healthy subjects - a randomized placebo-controlled human intervention study.

Background: Epidemiological studies reported an association between plasma phosphate concentrations and a higher risk for death and cardiovascular events in subjects free of chronic kidney diseases. The main aims of the present study were to determine the influence of a high phosphorus intake in com...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition Journal pp. 1 - 12
Autores principales: Trautvetter, Ulrike, Jahreis, Gerhard, Kiehntopf, Michael, Glei, Michael
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: BioMed Central 1/19/2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=112362848&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 112362848
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14752891
        1CYY
      jtl: Nutrition Journal
      issn: 14752891
      maglogo: N
    pubinfo:
      dt: 1/19/2016
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        112362848
        112362848
        NLM26786148
        112362848
        10.1186/s12937-016-0125-5
        NLM26786148
        PMC4717542
        112362848
      ppf: 1
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Consequences of a high phosphorus intake on mineral metabolism and bone remodeling in dependence of calcium intake in healthy subjects - a randomized placebo-controlled human intervention study.
      aug:
        au:
          Trautvetter, Ulrike
          Jahreis, Gerhard
          Kiehntopf, Michael
          Glei, Michael
        affil: Department of Nutritional Toxicology, Institute of Nutrition, Friedrich Schiller University Jena, Dornburger Straße 24, 07743 Jena, Germany
      sug:
        subj:
          Bone Density Drug Effects
          Bone Remodeling Drug Effects
          Phosphorus Administration and Dosage
          Calcium, Dietary Administration and Dosage
          Female
          Adult
          Dietary Supplements
          Human
          Male
          Research Subjects
          Phosphates Blood
          Magnesium Administration and Dosage
          Calcium, Dietary Urine
          Magnesium Urine
          Phosphorus Urine
          Double-Blind Studies
          Young Adult
          Renal Insufficiency, Chronic
          Growth Substances Blood
          Middle Age
          Calcium, Dietary Blood
          Diet Records
          Magnesium Blood
          Adolescence
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Randomized Controlled Trials
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Adolescent: 13-18 years
          Female
          Male
      ab: Background: Epidemiological studies reported an association between plasma phosphate concentrations and a higher risk for death and cardiovascular events in subjects free of chronic kidney diseases. The main aims of the present study were to determine the influence of a high phosphorus intake in combination with different calcium supplies on phosphorus, calcium, magnesium and iron metabolism as well as fibroblast growth factor 23 (FGF23) concentrations within eight weeks of supplementation.Methods: Sixty-two healthy subjects completed the double-blind, placebo-controlled parallel designed study. Supplements were monosodium phosphate and calcium carbonate. During the first two weeks, all groups consumed a placebo sherbet powder, and afterwards, for eight weeks, a sherbet powder according to the intervention group: P1000/Ca0 (1 g/d phosphorus), P1000/Ca500 (1 g/d phosphorus and 0.5 g/d calcium) and P1000/Ca1000 (1 g/d phosphorus and 1 g/d calcium). Dietary records, fasting blood samplings, urine and fecal collections took place.Results: Fasting plasma phosphate concentrations did not change after any intervention. After all interventions, renal excretions and fecal concentrations of phosphorus increased significantly after eight weeks. Renal calcium and magnesium excretion decreased significantly after eight weeks of P1000/Ca0 intervention compared to placebo. Plasma FGF23 concentrations were significantly higher after four weeks compared to eight weeks of all interventions.Conclusions: The long-term study showed in healthy adults no influence of high phosphorus intakes on fasting plasma phosphate concentrations. A high phosphorus intake without adequate calcium intake seems to have negative impact on calcium metabolism. Plasma FGF23 concentrations increased four weeks after high phosphorus intake and normalized after eight weeks.Trial Registration: The trial is registered at ClinicalTrials.gov as NCT02095392 .
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N